$4.60 Million in Sales Expected for Viveve Medical Inc (VIVE) This Quarter

Share on StockTwits

Wall Street brokerages expect Viveve Medical Inc (NASDAQ:VIVE) to report sales of $4.60 million for the current quarter, Zacks reports. Four analysts have made estimates for Viveve Medical’s earnings, with the highest sales estimate coming in at $4.92 million and the lowest estimate coming in at $4.37 million. Viveve Medical reported sales of $4.07 million in the same quarter last year, which indicates a positive year over year growth rate of 13%. The company is scheduled to announce its next earnings results on Wednesday, November 14th.

According to Zacks, analysts expect that Viveve Medical will report full-year sales of $21.61 million for the current fiscal year, with estimates ranging from $20.88 million to $22.17 million. For the next fiscal year, analysts expect that the company will report sales of $32.39 million, with estimates ranging from $29.12 million to $33.95 million. Zacks Investment Research’s sales averages are an average based on a survey of analysts that follow Viveve Medical.

Viveve Medical (NASDAQ:VIVE) last posted its quarterly earnings results on Thursday, August 9th. The company reported ($0.37) earnings per share for the quarter, beating the consensus estimate of ($0.38) by $0.01. The business had revenue of $5.53 million during the quarter, compared to analysts’ expectations of $4.97 million. Viveve Medical had a negative net margin of 239.33% and a negative return on equity of 551.85%.

Separately, ValuEngine lowered shares of Viveve Medical from a “buy” rating to a “hold” rating in a research note on Thursday, September 27th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $9.20.

VIVE traded down $0.17 during midday trading on Tuesday, reaching $3.47. 6,006 shares of the company’s stock were exchanged, compared to its average volume of 227,523. The company has a current ratio of 4.41, a quick ratio of 4.00 and a debt-to-equity ratio of 3.42. The stock has a market cap of $114.62 million, a P/E ratio of -1.73 and a beta of -0.21. Viveve Medical has a 1-year low of $1.60 and a 1-year high of $5.95.

A number of hedge funds have recently bought and sold shares of the business. LMR Partners LLP bought a new stake in shares of Viveve Medical in the 2nd quarter valued at about $112,000. Paloma Partners Management Co bought a new position in Viveve Medical in the second quarter valued at about $268,000. Northern Trust Corp raised its position in Viveve Medical by 43.4% in the first quarter. Northern Trust Corp now owns 252,974 shares of the company’s stock valued at $926,000 after purchasing an additional 76,519 shares during the last quarter. Marshall Wace LLP raised its position in Viveve Medical by 11.0% in the second quarter. Marshall Wace LLP now owns 441,279 shares of the company’s stock valued at $1,200,000 after purchasing an additional 43,842 shares during the last quarter. Finally, BlackRock Inc. raised its position in Viveve Medical by 8.1% in the first quarter. BlackRock Inc. now owns 780,591 shares of the company’s stock valued at $2,857,000 after purchasing an additional 58,256 shares during the last quarter. 61.99% of the stock is owned by institutional investors.

About Viveve Medical

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.

See Also: Risk Tolerance

Get a free copy of the Zacks research report on Viveve Medical (VIVE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Viveve Medical (NASDAQ:VIVE)

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Regional Health Properties Inc  Short Interest Up 3.9% in November
Regional Health Properties Inc Short Interest Up 3.9% in November
Titan International Inc  Announces Quarterly Dividend of $0.01
Titan International Inc Announces Quarterly Dividend of $0.01
WD-40  Increases Dividend to $0.61 Per Share
WD-40 Increases Dividend to $0.61 Per Share
Contrasting Willis Lease Finance  and Lawson Products
Contrasting Willis Lease Finance and Lawson Products
CryptoInsight 1-Day Trading Volume Tops $0.00
CryptoInsight 1-Day Trading Volume Tops $0.00
ODEM Price Reaches $0.19
ODEM Price Reaches $0.19


© 2006-2018 Ticker Report